COSMO Stock Financial Analysis - Farmacosmo S.p.A. (BIT) Stock

Overview

Farmacosmo S.p.A. is a prominent company based in Italy that operates within the pharmaceutical and healthcare product distribution industry. The company has carved out a significant niche by focusing on the rapid online sale and delivery of pharmaceutical, health, and wellness products. A key component of Farmacosmo's business strategy is leveraging advanced e-commerce technologies and logistics to ensure efficient service delivery across diverse Italian regions. Farmacosmo's commitment to expanding its digital footprint is evident in its continual investment in online platforms that enhance user experience and accessibility. This emphasis on technology integration facilitates swift customer service and positions Farmacosmo as a competitive player in the healthcare supplies market.

Quality, Value, Momentum Scores

This card shows the Quality, Value, and Momentum scores for the company

Quality

The QualityScore is a proprietary scoring model that identifies high quality companies, based on cash generating efficiencies.

Value

Proprietary scoring model that ranks companies based on their relative valuation. Scores range from 0 to 100, with 100 being the most undervalued.

Momentum

Proprietary scoring model that ranks companies on their six-month momentum.

Fund Sentiment

The Fund Sentiment (fka Ownership) score is a proprietary quantitative model that ranks companies based on levels of ownership accumulation.

QVM

The QVM Score is a proprietary scoring model that combines Quality, Value, and Momentum into a single metric that ranks companies from 0 to 100.

Income Statement: Revenue, Operating Income, Net Income

The revenue for Farmacosmo S.p.A. as of December 31, 2024 is 64.10 MM.
The operating income for Farmacosmo S.p.A. as of December 31, 2024 is -2.28 MM.
The net income for Farmacosmo S.p.A. as of December 31, 2024 is -2.97 MM.

Period End (TTM)	Revenue (MM)	Operating Income (MM)	Net Income (MM)
2024-12-31	64.10	-2.28	-2.97
2024-09-30	66.13	-2.48	-3.46
2024-06-30	68.16	-2.67	-3.94
2024-03-31	70.30	-2.96	-3.59
2023-12-31	72.44	-3.24	-3.23
2023-09-30	72.21	-3.14	-2.33
2023-06-30	71.78	-3.04	-1.42
2023-03-31	69.18	-2.34	-1.38
2022-12-31	66.59	-1.65	-1.34
2022-09-30	66.14	-0.48	-0.62
2022-06-30	64.20	1.02	0.34
2022-03-31	61.35	1.04	0.38
2021-12-31	58.50	1.07	0.41
2021-09-30	55.66	0.80	0.52
2020-12-31	44.48	0.87	0.37

Income Statement: EPS

Period End (TTM)	Earnings Per Share Basic	Earnings Per Share Diluted
2024-12-31
2024-09-30
2024-06-30	-0.10	-0.10
2024-03-31	-0.09	-0.09
2023-12-31	-0.08	-0.08
2023-09-30	-0.04	-0.04
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30	0.01	0.01
2022-03-31	0.01	0.01
2021-12-31	0.01	0.01
2021-09-30
2020-12-31

Cash Flow: Operations, Investing, Financing

The cash from operating activities for Farmacosmo S.p.A. as of December 31, 2024 is -2.13 MM.
The cash from investing activities for Farmacosmo S.p.A. as of December 31, 2024 is -0.45 MM.
The cash from financing activities for Farmacosmo S.p.A. as of December 31, 2024 is 0.64 MM.

Period End (TTM)	Cash From Operating Activities (MM)	Cash From Investing Activities (MM)	Cash From Financing Activities (MM)
2024-12-31	-2.13	-0.45	0.64
2024-09-30	-1.34	0.20	1.09
2024-06-30	-0.55	0.84	1.53
2024-03-31	-2.87	-0.25	3.14
2023-12-31	-5.18	-1.34	4.74
2023-09-30
2023-06-30
2023-03-31
2022-12-31
2022-09-30
2022-06-30
2022-03-31
2021-12-31	-0.28	-0.89	0.52
2021-09-30
2020-12-31	1.74	-0.52	-0.10

Valuation Metrics : PE, PriceToBook, PriceToTBV

The p/e for Farmacosmo S.p.A. as of December 31, 2024 is -5.28.
The p/book for Farmacosmo S.p.A. as of December 31, 2024 is 1.65.
The p/tbv for Farmacosmo S.p.A. as of December 31, 2024 is 18.49.

P/Book: The current closing price divided by the book value per share.

P/TBV: The current price divided by the tangible book value per share.

Period End (TTM)	p/e	P/Book	P/TBV
2024-12-31	-5.28	1.65	18.49
2024-09-30	-6.16	1.92	21.57
2024-06-30	-6.04	1.71	24.08
2024-03-31			-26.77
2023-12-31		1.41	-26.77
2023-09-30
2023-06-30		1.80	-3.02
2023-03-31		1.80	-3.02
2022-12-31			1.45
2022-09-30		1.23	4.23
2022-06-30	89.98	1.79	2.18
2022-03-31	81.42	1.80	2.19
2021-12-31	37.60	16.07	41.11
2021-09-30
2020-12-31

Valuation Metrics : EBitToEv, EBit3YrAvgToEv

The ebit/ev for Farmacosmo S.p.A. as of December 31, 2024 is -0.15.
The ebit (3y)/ev for Farmacosmo S.p.A. as of December 31, 2024 is -0.11.

Period End (TTM)	EBIT/EV	EBIT (3y)/EV
2024-12-31	-0.15	-0.11
2024-09-30	-0.13	-0.09
2024-06-30	-0.16	-0.05
2024-03-31	0.00	0.01
2023-12-31	0.00	0.00
2023-09-30
2023-06-30	-0.12	-0.03
2023-03-31	-0.10	-0.02
2022-12-31	0.00	0.02
2022-09-30	-0.05	-0.00
2022-06-30	0.02	0.02
2022-03-31	0.03	0.02
2021-12-31	0.04	0.03
2021-09-30
2020-12-31

Management Effectiveness

The roa for Farmacosmo S.p.A. as of December 31, 2024 is -0.11.
The roe for Farmacosmo S.p.A. as of December 31, 2024 is -0.22.
The roic for Farmacosmo S.p.A. as of December 31, 2024 is -0.21.
The croic for Farmacosmo S.p.A. as of December 31, 2024 is 0.09.
The ocroic for Farmacosmo S.p.A. as of December 31, 2024 is -0.03.

Period End (TTM)	ROA	ROE	ROIC	CROIC	OCROIC
2024-12-31	-0.11	-0.22	-0.21	0.09	-0.03
2024-09-30	-0.11	-0.22	-0.21	0.09	-0.03
2024-06-30			-0.15	-0.08	-0.23
2024-03-31
2023-12-31			0.00	0.00	0.00
2023-09-30
2023-06-30	0.00	0.00	0.00	0.00	0.00
2023-03-31	0.00	0.00	0.00	0.00	0.00
2022-12-31		0.00
2022-09-30		0.00
2022-06-30		0.00	0.00	0.00	0.00
2022-03-31		0.00
2021-12-31	0.05	0.75	0.26	-0.41	-0.18
2021-09-30			0.94	2.25	0.00
2020-12-31	0.08	0.98	0.57	1.90	1.76

Gross Margins

The gross margin for Farmacosmo S.p.A. as of December 31, 2024 is 0.01.
The net margin for Farmacosmo S.p.A. as of December 31, 2024 is -0.06.
The operating margin for Farmacosmo S.p.A. as of December 31, 2024 is -0.04.

Gross Margin: The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.

Net Margin: The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.

Operating Margin: The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.

Period End (TTM)	Gross Margin	Net Margin	Operating Margin
2024-12-31	0.01	-0.06	-0.04
2024-09-30	0.01	-0.06	-0.04
2024-06-30	0.01	-0.04	-0.04
2024-03-31
2023-12-31
2023-09-30
2023-06-30	0.00	0.00	-0.04
2023-03-31	0.00	0.00	-0.03
2022-12-31
2022-09-30	1.00	0.00	-0.01
2022-06-30	1.00	0.00	0.02
2022-03-31	1.00	0.00	0.02
2021-12-31	0.03	0.01	0.02
2021-09-30	0.03	0.01	0.01
2020-12-31	0.02	0.01	0.01